MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 76 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,117,879 | -35.0% | 138,867 | -12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,719,551 | -18.0% | 158,338 | -47.9% | 0.00% | 0.0% |
| Q1 2023 | $2,095,792 | +4403.0% | 303,738 | +2497.4% | 0.00% | – |
| Q4 2022 | $46,542 | -31.6% | 11,694 | -16.9% | 0.00% | – |
| Q2 2022 | $68,000 | -71.7% | 14,078 | -45.1% | 0.00% | – |
| Q1 2022 | $240,000 | -82.4% | 25,662 | -66.3% | 0.00% | – |
| Q2 2021 | $1,366,000 | +0.9% | 76,102 | -13.0% | 0.00% | – |
| Q1 2021 | $1,354,000 | +284.7% | 87,455 | +202.7% | 0.00% | – |
| Q4 2020 | $352,000 | -65.0% | 28,893 | -63.1% | 0.00% | – |
| Q3 2020 | $1,007,000 | – | 78,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |